Becoming a doctor is turning more difficult with each passing year. More graduates, more super-geniuses that don’t need to study to beat your MCAT scores. You shouldn’t only be recognized as competent because of a number you score on a test, you should be able to show potential employers that you are indeed worth their time. Introducing the new talent search engine for aspiring clinical candidates named DocDelta. Backed up by advanced analytics and Big Data, this is a great way to get ahead of the competition in your field.
Today John Dymond, CEO, takes us through the experience with BluePrint Health Acceelerator and his startup that’s set to hit the stage at demo day.
Tell us about the product or service.
DocDelta is the talent search engine for healthcare. We help hospitals gain an edge in the war for clinician talent and recruit more efficiently. We use big data and predictive algorithms to identify passive clinicians candidates with the itch to move before anyone knows about them.
How is it different?
We are the first company to use big data and predictive algorithms in the healthcare talent recruitment space. Cutting edge HR tech companies like TalentBin, Entelo and others have been pioneers using predictive analytics in the west coast software development space but we are the first team to bring this technology to healthcare recruiting.
What market are you attacking and how big is it?
Our first market is the US provider and healthcare staffing space, an addressable market of around $2 billion.
What is the business model?
Clients pay us a monthly subscription fee to access our searchable recruitment platform. We have premium products for strategic acquisition and retention in the pipeline.
Tell us about the experience participating in BluePrint Health…
Initially I was worried about the value we would gain vs. the equity we give up. However joining BluePrint has been one of the best decisions we made: we have been able to rub shoulders with the elite healthcare tech investors in NY, we have secured our first clients and started a number of ongoing relationships with heavy hitters in the largest NY hospitals. We joined BluePrint with an idea, and we are leaving the program with a business.
What are the milestones that you plan to achieve within six months?
Besides closing our series A round, we are focused on expanding our sales effort across the tristate area and launching premium versions of our product to support hospital acquisition and retention activities.
If you could be put in touch with one investor in the New York community who would it be and why?
James Flynn of Deerfield Capital. Deerfield is one of the leading healthcare tech investors with experience in the healthcare scene since the early 2000’s.
Why did you launch in New York?
I live in NYC, and the tristate area is the centre of the healthcare world.
Where is your favorite place to visit in the area in the fall.
The Prospect Park Zoo with my daughter
